[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![Metsera, Inc. Common Stock Graphic](https://lunarcrush.com/gi/w:26/t:$mtsr.png) Metsera, Inc. Common Stock (MTSR)

Pfizer acquires Metsera for $XXX billion, sending MTSR shares soaring. The deal gives Pfizer a foothold in the booming obesity treatment market.

### About Metsera, Inc. Common Stock
Metsera, Inc. Common Stock (MTSR) is a stock of a company focused on developing protein drugs for obesity treatment.  
Metsera, Inc. Common Stock uses the ticker $MTSR for trading. Listed in the [Stocks](/list/stocks) and  category.

### Price: $XX [#](/topic/$mtsr/close)
---
![Price Line Chart](https://lunarcrush.com/gi/w:600/t:$mtsr/c:line/m:close/iv:1d.svg)  
[Price 24-Hour Time-Series Raw Data](/topic/$mtsr/time-series/close.tsv)  
The price action is likely driven by the Pfizer acquisition news, with the stock price hitting a 52-week high. The positive sentiment from the acquisition and the potential of Metsera's pipeline are likely contributing to the price increase.  

| 24-Hour | 7-Day | 30-Day |
| ------- | ----- | ------ |
| XXXX%   | XXXX% | XXXXX% |

**1-Year High**: $XXXXX on 2025-09-22  
**1-Year Low**: $XXXXX on 2025-04-10  
  
  
### AltRank: XXXXX [#](/topic/$mtsr/alt_rank)
---
![AltRank Line Chart](https://lunarcrush.com/gi/w:600/t:$mtsr/c:line/m:alt_rank/iv:1d.svg)  
[AltRank 24-Hour Time-Series Raw Data](/topic/$mtsr/time-series/alt_rank.tsv)  
Metsera, Inc. Common Stock (MTSR) is currently AltRank #1,331 based on combined combined social and market metrics
**Daily Average**: XXXXX  
**1 Week**: XXXXX +1,067  
**1 Month**: XXXXX +1,096  
**6 Months**: XXXXX +947  
**1 Year**: XXXXX -XXX  
**1-Year High**: XXXXX on 2025-07-28  
**1-Year Low**: XX on 2025-09-22  
  
  
### Galaxy Score: XXXXX [#](/topic/$mtsr/galaxy_score)
---
![Galaxy Score Line Chart](https://lunarcrush.com/gi/w:600/t:$mtsr/c:line/m:galaxy_score/iv:1d.svg)  
[Galaxy Score 24-Hour Time-Series Raw Data](/topic/$mtsr/time-series/galaxy_score.tsv)  
**Current Value**: XXXXX  
**Daily Average**: XX  
**1 Week**: XX -XX  
**1 Month**: XX -XX  
**6 Months**: XX -XX  
**1 Year**: XX +20  
**1-Year High**: XX on 2025-09-22  
**1-Year Low**: XX on 2025-05-09  
  
  
### Engagements: XXXXX [#](/topic/$mtsr/interactions)
---
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$mtsr/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$mtsr/time-series/interactions.tsv)  
**Current Value**: XXXXX  
**Daily Average**: XXXXXX  
**1 Week**: XXXXXX -XX%  
**1 Month**: XXXXXXXXX +386%  
**6 Months**: XXXXXXXXX +374%  
**1 Year**: XXXXXXXXX +307%  
**1-Year High**: XXXXXXX on 2025-09-22  
**1-Year Low**: X on 2024-10-26  

| Social Network | X     | YouTube |
| -------------- | -     | ------- |
| Engagements    | XXXXX | X       |
  

  
  
### Mentions: XX [#](/topic/$mtsr/posts_active)
---
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$mtsr/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$mtsr/time-series/posts_active.tsv)  
**Current Value**: XX  
**Daily Average**: XX  
**1 Month**: XXXXX +335%  
**6 Months**: XXXXX +833%  
**1 Year**: XXXXX +14,137%  
**1-Year High**: XXXXX on 2025-09-23  
**1-Year Low**: X on 2024-10-26  

| Social Network | X  | YouTube |
| -------------- | -  | ------- |
| Mentions       | XX | X       |
  

  
  
### Creators: XX [#](/topic/$mtsr/contributors_active)
---
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$mtsr/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$mtsr/time-series/contributors_active.tsv)  
XX unique social accounts have posts mentioning Metsera, Inc. Common Stock (MTSR) in the last XX hours which is down XX% from XX in the previous XX hours
**Daily Average**: XX  
**1 Month**: XXX +402%  
**6 Months**: XXXXX +1,172%  
**1 Year**: XXXXX +9,805%  
**1-Year High**: XXXXX on 2025-09-23  
**1-Year Low**: X on 2024-10-22  

The most influential creators that mention Metsera, Inc. Common Stock in the last XX hours

| Creator                                              | Rank | Followers | Posts | Engagements |
| -------                                              | ---- | --------- | ----- | ----------- |
| [@BiopharmIQ](/creator/twitter/BiopharmIQ)           | X    | XXXXXX    | X     | XXX         |
| [@bioinvestor24](/creator/twitter/bioinvestor24)     | X    | XXXXX     | X     | XX          |
| [@investseekers](/creator/twitter/investseekers)     | X    | XXXXX     | X     | XX          |
| [@PersimmonTI](/creator/twitter/PersimmonTI)         | X    | XXXXXX    | X     | XX          |
| [@balaprasadparm3](/creator/twitter/balaprasadparm3) | X    | X         | X     | X           |
| [@themarketuni](/creator/twitter/themarketuni)       | X    | XXXXX     | X     | X           |
| [@HarpA70278288](/creator/twitter/HarpA70278288)     | X    | X         | X     | X           |

[View More](/list/creators/$mtsr/100)
  
  
### Sentiment: XX% [#](/topic/$mtsr/sentiment)
---
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$mtsr/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$mtsr/time-series/sentiment.tsv)  
**Current Value**: XX%  
**Daily Average**: XX%  
**1 Week**: XX% +1%  
**1 Month**: XX% -X%  
**6 Months**: XX% -XX%  
**1 Year**: XX% -XX%  
**1-Year High**: XXX% on 2024-11-20  
**1-Year Low**: XX% on 2025-01-13  

**Most Supportive Themes**
- **Pfizer Acquisition:** (55%) Pfizer's acquisition of Metsera is viewed as a major positive, injecting capital and resources into the company's obesity drug pipeline.
- **Positive Data and Pipeline:** (25%) The potential of Metsera's lead drug and other molecules in the clinic, along with the company's innovative technology, are highlighted as key strengths.
- **Market Opportunity:** (10%) The booming obesity treatment market and the potential for Metsera to capture a significant share are driving positive sentiment.
  
**Most Critical Themes**
- **Valuation Concerns:** (5%)  Some investors question whether the acquisition price is justified, especially compared to the valuations of other companies in the space.
- **Competition:** (5%)  The competitive landscape in the obesity drug market, with established players like Eli Lilly and Novo Nordisk, poses a challenge.
  
Network engagement breakdown:  
| Network | Positive | %   | Neutral | %   | Negative | %   |
| ------- | -------- | -   | ------- | -   | -------- | -   |
| X       | XXXXX    | XX% | XXX     | XX% | XXX      | XX% |
| YouTube | X        | X%  | X       | X%  | X        | X%  |
|         |          |     |         |     |          |     |
| Total   | XXXXX    | XX% | XXX     | XX% | XXX      | XX% |
  

  
  
### Social Dominance: XXXXXXX% [#](/topic/$mtsr/social_dominance)
---
![Social Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$mtsr/c:line/m:social_dominance/iv:1d.svg)  
[Social Dominance 24-Hour Time-Series Raw Data](/topic/$mtsr/time-series/social_dominance.tsv)  
**Current Value**: XXXXXXX%  
**Daily Average**: XXXXX%  
**1 Week**: XXXXXX% -XXXXXXXXXXXXXXXXXXXXX%  
**1 Month**: XXXXXX% +0.0069%  
**6 Months**: XXXXXX% -XXXXXX%  
**1 Year**: XXXXXX% +0.0094%  
**1-Year High**: XXXXX% on 2025-09-23  
**1-Year Low**: XXXXXX% on 2024-12-07  
  
  
### Market Dominance: XXXXXXX% [#](/topic/$mtsr/market_dominance)
---
![Market Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$mtsr/c:line/m:market_dominance/iv:1d.svg)  
[Market Dominance 24-Hour Time-Series Raw Data](/topic/$mtsr/time-series/market_dominance.tsv)  
**Current Value**: XXXXXXX%  
**Daily Average**: X%  
**1-Year High**: XXXXX% on 2025-03-31  
**1-Year Low**: XXXXXXX% on 2025-04-10  
  
  
### Market Cap: $XXXXXXXXXXXXX [#](/topic/$mtsr/market_cap)
---
![Market Cap Line Chart](https://lunarcrush.com/gi/w:600/t:$mtsr/c:line/m:market_cap/iv:1d.svg)  
[Market Cap 24-Hour Time-Series Raw Data](/topic/$mtsr/time-series/market_cap.tsv)  
**Current Value**: $XXXXXXXXXXXXX  
**Daily Average**: $XXXXXXXXXXXXX  
**1 Week**: $XXXXXXXXXXXXX +$1.10%  
**1 Month**: $XXXXXXXXXXXXX +$48%  
**6 Months**: $XXXXXXXXXXXXX +$172%  
**1-Year High**: $XXXXXXXXXXXXX on 2025-09-22  
**1-Year Low**: $XXXXXXXXXXXXX on 2025-04-10  

**Top assets mentioned**
In the posts about Metsera, Inc. Common Stock in the last XX hours

[Viking Therapeutics, Inc (VKTX)](/topic/$vktx)
[Pfizer, Inc. (PFE)](/topic/$pfe)
[Novo-Nordisk (NVO)](/topic/$nvo)
[Eli Lilly and Company (LLY)](/topic/eli-lilly)
[Bitcoin Incognito (XBI)](/topic/$xbi)
[Tourmaline Bio, Inc. Common Stock (TRML)](/topic/$trml)
[Akropolis (AKRO)](/topic/$akro)
[Insmed, Inc. (INSM)](/topic/$insm)
[Oklo Inc. (OKLO)](/topic/$oklo)

**Top topics mentioned**
In the posts about Metsera, Inc. Common Stock in the last XX hours

[stocks healthcare](/topic/stocks-healthcare), [$vktx](/topic/$vktx), [$pfe](/topic/$pfe), [$nvo](/topic/$nvo), [eli lilly](/topic/eli-lilly), [$xbi](/topic/$xbi), [$gpcr](/topic/$gpcr), [$etnb](/topic/$etnb), [$trml](/topic/$trml), [has been](/topic/has-been), [acquisition](/topic/acquisition), [$akro](/topic/$akro), [investment](/topic/investment), [$insm](/topic/$insm), [investments](/topic/investments), [$oklo](/topic/$oklo), [stocks bitcoin treasuries](/topic/stocks-bitcoin-treasuries), [$mrk](/topic/$mrk), [$abbv](/topic/$abbv), [$mrus](/topic/$mrus), [stocks](/topic/stocks), [$psnl](/topic/$psnl), [$cytk](/topic/$cytk), [$ions](/topic/$ions), [$imvt](/topic/$imvt), [$zeal](/topic/$zeal), [novartis](/topic/novartis), [$ssrm](/topic/$ssrm), [stocks consumer cyclical](/topic/stocks-consumer-cyclical), [stocks consumer defensive](/topic/stocks-consumer-defensive), [$hrow](/topic/$hrow), [$sndx](/topic/$sndx), [$angi](/topic/$angi), [$arbe](/topic/$arbe), [$10b](/topic/$10b), [$375b](/topic/$375b), [$808m](/topic/$808m), [$lly](/topic/$lly), [$amgn](/topic/$amgn), [$mens](/topic/$mens), [$mdgl](/topic/$mdgl), [$ptgx](/topic/$ptgx), [$abvx](/topic/$abvx), [stocks technology](/topic/stocks-technology), [united therapeutics corp](/topic/united-therapeutics-corp), [$uthr](/topic/$uthr), [$mltx](/topic/$mltx), [behind the](/topic/behind-the), [$bpmc](/topic/$bpmc), [$vrna](/topic/$vrna), [$bbio](/topic/$bbio), [$rna](/topic/$rna), [$apge](/topic/$apge), [$cgem](/topic/$cgem), [$pmvp](/topic/$pmvp), [$atyr](/topic/$atyr), [$1530hk](/topic/$1530hk), [$20s](/topic/$20s), [$novnsw](/topic/$novnsw), [$nvs](/topic/$nvs), [$quremy](/topic/$quremy), [$paas](/topic/$paas), [$qure](/topic/$qure), [$220b](/topic/$220b), [$usar](/topic/$usar), [autocrypto](/topic/autocrypto), [coins bsc](/topic/coins-bsc), [coins ai](/topic/coins-ai), [$au](/topic/$au), [$azn](/topic/$azn), [biogen inc](/topic/biogen-inc), [$biib](/topic/$biib), [$csan](/topic/$csan), [$qubt](/topic/$qubt), [bitmine](/topic/bitmine), [$imgn](/topic/$imgn), [money](/topic/money), [johnson johnson](/topic/johnson-johnson), [$jnj](/topic/$jnj), [$rhhby](/topic/$rhhby), [$vor](/topic/$vor), [$gdxd](/topic/$gdxd), [$qmmm](/topic/$qmmm), [$bhf](/topic/$bhf), [$crbu](/topic/$crbu), [$sony](/topic/$sony), [$mo](/topic/$mo), [$rprx](/topic/$rprx), [$puk](/topic/$puk), [$tars](/topic/$tars), [$35b](/topic/$35b), [$joby](/topic/$joby), [market cap](/topic/market-cap), [$spy](/topic/$spy), [cancelled](/topic/cancelled), [$qqq](/topic/$qqq), [$iwm](/topic/$iwm), [$beta](/topic/$beta), [$crwv](/topic/$crwv), [$krmn](/topic/$krmn)

### Top Social Posts [#](/topic/$mtsr/posts)
---
Top posts by engagements in the last XX hours

*Showing only X posts for non-authenticated requests. Use your API key in requests for full results.*

"Air Taxi $BETA IPO Eyes XXXX Billion Valuation **Other Leading New Issues This Year $MENS $CRCL $CRWV $KRMN $MTSR $AAPG $MIAX $WYFI"  
[X Link](https://x.com/STaylor76084368/status/1979643980859248715) [@STaylor76084368](/creator/x/STaylor76084368) 2025-10-18T20:21Z XXX followers, XXX engagements


"Best stock advice right now Investing in zero revenues unicorns. YEAR-TO-DATE HEAT MAP OF STOCKS WITH $1B+ MARKET CAP & $1M REVENUES $OKLO +642% $JOBY +98% $CALC -X% $NEUP +417% $SNSE +3313% $MTSR +99% $QUBT 0%"  
[X Link](https://x.com/ValueSense_io/status/1979366868885328152) [@ValueSense_io](/creator/x/ValueSense_io) 2025-10-18T02:00Z 42.3K followers, 3007 engagements


"$AZN $PFE $LLY $GILD $NVO $GSK $JNJ $GMAB $MRUS $ZLDPF $RHHBY $MTSR $ABBV $MRK $NVS $SNN $ZBH Listen to Washington J&J Orpho Spin Eyecare Merus Deal: BI Drug Call by Bloomberg Intelligence #np on #SoundCloud"  
[X Link](https://x.com/SamFazeli8/status/1979126760215065009) [@SamFazeli8](/creator/x/SamFazeli8) 2025-10-17T10:06Z 2881 followers, XXX engagements


"$SONY $MO $RPRX $MTSR $D $PUK $BHP and $DB are forming an excellent breakout setup pattern"  
[X Link](https://x.com/ChartMill/status/1978642048992366703) [@ChartMill](/creator/x/ChartMill) 2025-10-16T02:00Z 11.2K followers, XXX engagements

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

Metsera, Inc. Common Stock (MTSR)

Pfizer acquires Metsera for $XXX billion, sending MTSR shares soaring. The deal gives Pfizer a foothold in the booming obesity treatment market.

About Metsera, Inc. Common Stock

Metsera, Inc. Common Stock (MTSR) is a stock of a company focused on developing protein drugs for obesity treatment.
Metsera, Inc. Common Stock uses the ticker $MTSR for trading. Listed in the Stocks and category.

Price: $XX #

Price 24-Hour Time-Series Raw Data
The price action is likely driven by the Pfizer acquisition news, with the stock price hitting a 52-week high. The positive sentiment from the acquisition and the potential of Metsera's pipeline are likely contributing to the price increase.

24-Hour	7-Day	30-Day
XXXX%	XXXX%	XXXXX%

1-Year High: $XXXXX on 2025-09-22
1-Year Low: $XXXXX on 2025-04-10

AltRank: XXXXX #

AltRank Line Chart
AltRank 24-Hour Time-Series Raw Data
Metsera, Inc. Common Stock (MTSR) is currently AltRank #1,331 based on combined combined social and market metrics Daily Average: XXXXX
1 Week: XXXXX +1,067
1 Month: XXXXX +1,096
6 Months: XXXXX +947
1 Year: XXXXX -XXX
1-Year High: XXXXX on 2025-07-28
1-Year Low: XX on 2025-09-22

Galaxy Score: XXXXX #

Galaxy Score Line Chart
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XX
1 Week: XX -XX
1 Month: XX -XX
6 Months: XX -XX
1 Year: XX +20
1-Year High: XX on 2025-09-22
1-Year Low: XX on 2025-05-09

Engagements: XXXXX #

Engagements Line Chart
Engagements 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XXXXXX
1 Week: XXXXXX -XX%
1 Month: XXXXXXXXX +386%
6 Months: XXXXXXXXX +374%
1 Year: XXXXXXXXX +307%
1-Year High: XXXXXXX on 2025-09-22
1-Year Low: X on 2024-10-26

Social Network	X	YouTube
Engagements	XXXXX	X

Mentions: XX #

Mentions Line Chart
Mentions 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XX
1 Month: XXXXX +335%
6 Months: XXXXX +833%
1 Year: XXXXX +14,137%
1-Year High: XXXXX on 2025-09-23
1-Year Low: X on 2024-10-26

Social Network	X	YouTube
Mentions	XX	X

Creators: XX #

Creators Line Chart
Creators 24-Hour Time-Series Raw Data
XX unique social accounts have posts mentioning Metsera, Inc. Common Stock (MTSR) in the last XX hours which is down XX% from XX in the previous XX hours Daily Average: XX
1 Month: XXX +402%
6 Months: XXXXX +1,172%
1 Year: XXXXX +9,805%
1-Year High: XXXXX on 2025-09-23
1-Year Low: X on 2024-10-22

The most influential creators that mention Metsera, Inc. Common Stock in the last XX hours

Creator	Rank	Followers	Posts	Engagements
@BiopharmIQ	X	XXXXXX	X	XXX
@bioinvestor24	X	XXXXX	X	XX
@investseekers	X	XXXXX	X	XX
@PersimmonTI	X	XXXXXX	X	XX
@balaprasadparm3	X	X	X	X
@themarketuni	X	XXXXX	X	X
@HarpA70278288	X	X	X	X

Sentiment: XX% #

Sentiment Line Chart
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
1 Week: XX% +1%
1 Month: XX% -X%
6 Months: XX% -XX%
1 Year: XX% -XX%
1-Year High: XXX% on 2024-11-20
1-Year Low: XX% on 2025-01-13

Most Supportive Themes

Pfizer Acquisition: (55%) Pfizer's acquisition of Metsera is viewed as a major positive, injecting capital and resources into the company's obesity drug pipeline.
Positive Data and Pipeline: (25%) The potential of Metsera's lead drug and other molecules in the clinic, along with the company's innovative technology, are highlighted as key strengths.
Market Opportunity: (10%) The booming obesity treatment market and the potential for Metsera to capture a significant share are driving positive sentiment.

Most Critical Themes

Valuation Concerns: (5%) Some investors question whether the acquisition price is justified, especially compared to the valuations of other companies in the space.
Competition: (5%) The competitive landscape in the obesity drug market, with established players like Eli Lilly and Novo Nordisk, poses a challenge.

Network engagement breakdown:

Network	Positive	%	Neutral	%	Negative	%
X	XXXXX	XX%	XXX	XX%	XXX	XX%
YouTube	X	X%	X	X%	X	X%

Total	XXXXX	XX%	XXX	XX%	XXX	XX%

Social Dominance: XXXXXXX% #

Social Dominance Line Chart
Social Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXXXX%
Daily Average: XXXXX%
1 Week: XXXXXX% -XXXXXXXXXXXXXXXXXXXXX%
1 Month: XXXXXX% +0.0069%
6 Months: XXXXXX% -XXXXXX%
1 Year: XXXXXX% +0.0094%
1-Year High: XXXXX% on 2025-09-23
1-Year Low: XXXXXX% on 2024-12-07

Market Dominance: XXXXXXX% #

Market Dominance Line Chart
Market Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXXXX%
Daily Average: X%
1-Year High: XXXXX% on 2025-03-31
1-Year Low: XXXXXXX% on 2025-04-10

Market Cap: $XXXXXXXXXXXXX #

Market Cap Line Chart
Market Cap 24-Hour Time-Series Raw Data
Current Value: $XXXXXXXXXXXXX
Daily Average: $XXXXXXXXXXXXX
1 Week: $XXXXXXXXXXXXX +$1.10%
1 Month: $XXXXXXXXXXXXX +$48%
6 Months: $XXXXXXXXXXXXX +$172%
1-Year High: $XXXXXXXXXXXXX on 2025-09-22
1-Year Low: $XXXXXXXXXXXXX on 2025-04-10

Top assets mentioned In the posts about Metsera, Inc. Common Stock in the last XX hours

Viking Therapeutics, Inc (VKTX) Pfizer, Inc. (PFE) Novo-Nordisk (NVO) Eli Lilly and Company (LLY) Bitcoin Incognito (XBI) Tourmaline Bio, Inc. Common Stock (TRML) Akropolis (AKRO) Insmed, Inc. (INSM) Oklo Inc. (OKLO)

Top topics mentioned In the posts about Metsera, Inc. Common Stock in the last XX hours

stocks healthcare, $vktx, $pfe, $nvo, eli lilly, $xbi, $gpcr, $etnb, $trml, has been, acquisition, $akro, investment, $insm, investments, $oklo, stocks bitcoin treasuries, $mrk, $abbv, $mrus, stocks, $psnl, $cytk, $ions, $imvt, $zeal, novartis, $ssrm, stocks consumer cyclical, stocks consumer defensive, $hrow, $sndx, $angi, $arbe, $10b, $375b, $808m, $lly, $amgn, $mens, $mdgl, $ptgx, $abvx, stocks technology, united therapeutics corp, $uthr, $mltx, behind the, $bpmc, $vrna, $bbio, $rna, $apge, $cgem, $pmvp, $atyr, $1530hk, $20s, $novnsw, $nvs, $quremy, $paas, $qure, $220b, $usar, autocrypto, coins bsc, coins ai, $au, $azn, biogen inc, $biib, $csan, $qubt, bitmine, $imgn, money, johnson johnson, $jnj, $rhhby, $vor, $gdxd, $qmmm, $bhf, $crbu, $sony, $mo, $rprx, $puk, $tars, $35b, $joby, market cap, $spy, cancelled, $qqq, $iwm, $beta, $crwv, $krmn